As expected, addition of a Y1R antagonist BIBP3226 was able to block NPY-induced upregulation of Y1R signaling, thereby enhancing NF-κB-Mincle-mediated M1 macrophage activation and renal necroinflammation in AKI mice and in vitro. Here, NFKB1 is linked to acute kidney injury.